179 related articles for article (PubMed ID: 16961643)
1. Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination.
Legout L; Senneville E; Stern R; Yazdanpanah Y; Savage C; Roussel-Delvalez M; Rosele B; Migaud H; Mouton Y
Clin Microbiol Infect; 2006 Oct; 12(10):1030-3. PubMed ID: 16961643
[TBL] [Abstract][Full Text] [Related]
2. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
[TBL] [Abstract][Full Text] [Related]
4. Cefepime effectiveness in Gram-negative bloodstream infections.
Al-Hasan MN; Eckel-Passow JE; Baddour LM
J Antimicrob Chemother; 2011 May; 66(5):1156-60. PubMed ID: 21393128
[TBL] [Abstract][Full Text] [Related]
5. Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
Belliveau P; Nightingale CH; Quintiliani R; Crowe H; Gousee G
Conn Med; 1993 Aug; 57(8):539-45. PubMed ID: 8243083
[TBL] [Abstract][Full Text] [Related]
6. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
[TBL] [Abstract][Full Text] [Related]
7. Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections.
Finney MS; Crank CW; Segreti J
Curr Med Res Opin; 2005 Dec; 21(12):1923-6. PubMed ID: 16368041
[TBL] [Abstract][Full Text] [Related]
8. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of cefepime in the treatment of serious bacterial infections in hospitalized adult patients.
Sheng WH; Wang JT; Chang SC
J Microbiol Immunol Infect; 2000 Jun; 33(2):109-14. PubMed ID: 10917881
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of antibiotic-lock therapy for long-term catheter-related bacteremia due to Gram-negative bacilli: a prospective observational study.
Funalleras G; Fernández-Hidalgo N; Borrego A; Almirante B; Planes AM; Rodríguez D; Ruiz I; Pahissa A
Clin Infect Dis; 2011 Nov; 53(9):e129-32. PubMed ID: 21890750
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance pattern of Gram-negative bacilli of nosocomial origin at 2 university hospitals in Iran.
Hadadi A; Rasoulinejad M; Maleki Z; Yonesian M; Shirani A; Kourorian Z
Diagn Microbiol Infect Dis; 2008 Mar; 60(3):301-5. PubMed ID: 18036759
[TBL] [Abstract][Full Text] [Related]
12. [Teicoplanin in the treatment of bone and joint infections due to methicillin resistant staphylococci. Experience in adult patients].
Pensotti C; Nacinovich F; Vidiella G; Carbone E; Marin M; Di Stéfano C; Stamboulian D
Medicina (B Aires); 2002; 62 Suppl 2():40-7. PubMed ID: 12481488
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.
Del Pozo JL; Alonso M; Serrera A; Hernaez S; Aguinaga A; Leiva J
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):208-12. PubMed ID: 19026506
[TBL] [Abstract][Full Text] [Related]
14. Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B.
Pereira GH; Muller PR; Levin AS
Diagn Microbiol Infect Dis; 2007 Jun; 58(2):235-40. PubMed ID: 17350201
[TBL] [Abstract][Full Text] [Related]
15. [Otitis externa: which antibiotics are first choice?].
MMW Fortschr Med; 2006 Aug; 148(33-34):12. PubMed ID: 16981377
[No Abstract] [Full Text] [Related]
16. Failure of cefepime therapy in neutropenic patients with extended-spectrum beta-lactamase-producing Gram-negative bacteraemia.
Wi YM; Kang CI; Cheong HS; Chung DR; Jung CW; Ko KS; Song JH; Peck KR
Int J Antimicrob Agents; 2009 Apr; 33(4):384-6. PubMed ID: 19097866
[No Abstract] [Full Text] [Related]
17. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
[TBL] [Abstract][Full Text] [Related]
18. Cefamandole in the treatment of serious bone and joint diseases.
Levine LR
Scand J Infect Dis Suppl; 1980; suppl 25():89-93. PubMed ID: 7010542
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of injectable ofloxacin in treating septicemia. Multicenter study].
Doco-Lecompte T; Modaï J
Pathol Biol (Paris); 1989 May; 37(5):465-7. PubMed ID: 2674872
[TBL] [Abstract][Full Text] [Related]
20. Oral ciprofloxacin in refractory gram-negative bacillary infections.
Bryant RE; Hartstein AI
Int J Clin Pharmacol Res; 1987; 7(3):187-94. PubMed ID: 3596862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
